The field of psychedelic medicine is a decades old, re-emerging field of research and clinical practice that has gained significant and increasing attention over the past few years – in large part due to the growing burden of mental illness, the lack of innovation in other treatment modalities, and the staggering results of psychedelic-assisted therapies seen thus far.
The Psychedelic Medicine whitepaper provides a comprehensive overview of this emerging field, including the current challenges in mental health treatments, the socioeconomic impact of treatment-resistant conditions, ketamine-assisted psychotherapy, research into other psychedelic substances, evolving local and federal policy, as well as Field Trip Health’s approach to psychedelic-assisted therapy.
Download your copy for a detailed and research-backed look at the field of psychedelic medicine today, and for a glimpse into the future of mental healthcare.
To learn more, tune in to Field Trip Health's webinar on Wednesday Feb 3 at 7 PM with Dr. Ben Medrano, medical director of our New York center. Sign up by clicking here.